is the widely expressed primary binding partner for IL-15. Because of the wide distribution in nonlymphoid tissues like skeletal muscle, adipose, or liver, IL-15/IL-15R␣ take part in physiological and metabolic processes not directly related to immunity. In fast muscle, lack of IL-15R␣ promotes an oxidative switch, with increased mitochondrial biogenesis and fatigue resistance. These effects are predicted to reproduce some of the benefits of exercise and, therefore, improve energy homeostasis. However, the direct effects of IL-15R␣ on metabolism and obesity are currently unknown. We report that mice lacking IL-15R␣ (IL-15R␣ Ϫ/Ϫ ) are resistant to diet-induced obesity (DIO). High-fat diet-fed IL-15R␣ Ϫ/Ϫ mice have less body and liver fat accumulation than controls. The leaner phenotype is associated with increased energy expenditure and enhanced fatty acid oxidation by muscle mitochondria. Despite being protected against DIO, IL-15R␣ Ϫ/Ϫ are hyperglycemic and insulin-resistant. These findings identify novel roles for IL-15R␣ in metabolism and obesity.
ACCUMULATION OF EXCESSIVE body fat is a physiological consequence of unnecessary caloric intake. With greater worldwide food production, often the caloric intake largely exceeds the physiological energy requirements, and as a result, the obesity pandemic is growing at alarming rates in both developed and developing countries (21, 47) . Apart from the role of environmental factors, particularly an energy-dense diet and sedentary lifestyle, obesity also has important genetic determinants that have been conserved across species. Identifying the molecular mechanisms regulating metabolic efficiency (the capacity to convert energy intake into storable energy forms) is of great interest because of the low success in using caloric restriction as a means to manage obesity. Indeed, a number of pathways have been recently identified that reduce the extent of dietinduced obesity (DIO) by decreasing metabolic efficiency rather than energy input (8, 10, 11, 43, 56, 59, 60) . Targeting these pathways with pharmacological approaches may also have the advantage of reproducing some of the benefits normally associated with physical exercise. Together with caloric restriction, exercise is a mainstay of a healthy life style and contributes to the control of metabolic efficiency. In addition to converting energy into movement, exercise increases the rates of lipolysis and fat oxidation, promotes heat dissipation (49, 53) , and causes long-term changes in the expression of numerous genes, including IL-15R␣/IL-15 (55) .
IL-15 and its primary binding partner IL-15R␣ have emerged as important regulators of cell functions in both lymphoid and nonlymphoid tissues. Their transcripts are detectable in a variety of tissues, including skeletal muscle, liver, or adipose (http://biogps.org/#gotoϭwelcome). Some of the proposed noncanonical roles of IL-15/IL-15R␣ signaling are mediating anabolic signaling and changing the oxidative properties of muscle (28, 29, 33, 34, 36, 40) . IL-15 levels increase in muscles of endurance-trained individuals (44) . Oversecretion of IL-15 from muscle is associated with reduced adiposity, resistance to DIO, and improved insulin sensitivity (38, 39) , suggesting that IL-15 can function as myokine (i.e., molecules secreted by the muscle and able to mediate effects on different tissues) (32, 44) . Interestingly, mice lacking IL-15R␣ and mice overexpressing IL-15 share some common features like increased muscle oxidative capacity and fatigue resistance (33, 34, 37, 28) .
IL-15R␣ does not have intrinsic kinase activity; therefore, its primary biological function is to bind IL-15 and allow its transpresentation to cells expressing IL-2/15R␤ and ␥ c (46) . A shed form of IL-15R␣ is also present in the bloodstream where it binds and increases the half-life of IL-15 (24, 25) . The use of a whole-body IL-15R␣ knockout murine model, therefore, allows one to study the effects of the global lack of IL-15R␣, excluding the confounding effects attributable to its soluble form.
We previously showed that mice lacking IL-15R␣ have increased spontaneous activity, and their muscles have improved endurance and higher mitochondria content (34) . In parallel with these experimental results, a SNP on exon 3 of the IL15Ra gene (rs2228059) showed significant association with endurance performance in elite athletes (34) and with lower serum triglycerides in males (35) . In this study, we tested the hypothesis that lack of IL-15R␣ can alter whole body, as well as muscle metabolism and be protective against DIO. We show that lack of IL-15R␣ protects against DIO, increases energy expenditure, and promotes the utilization of fatty acids in muscle at the expense of glucose tolerance.
MATERIALS AND METHODS
Mice. All animal experiments were conducted in accordance with protocols approved by the Institutional Animal Care and Use Com- Values are expressed as means Ϯ SE. Relative mass was calculated in reference to lean mass as obtained by NMR analysis (n ϭ 10 mice). Ctrl, control; NC, normal chow; HFD, high-fat diet; EDL, extensor digitorum longus; TA, tibialis anterior. ***P Ͻ 0.001, **P Ͻ 0.01, *P Ͻ 0.05. mittee of the University of Pennsylvania. Ten-week-old B6;129X1-Il15raϽtm1AmaϾ/J (IL15Ra Ϫ/Ϫ ; stock no. 003723) and control B6129SF2/J (stock no. 101045) mice were purchased from the Jackson Laboratory (Bar Harbor, ME) and maintained on normal chow (LabDiet, cat. no. 5001; 3.36 kcal/g, 28% protein, 57% carbohydrates, and 13% fat) or 45% fat chow (Research Diets, cat. no. 12451; 4.7 kcal/g, 20% protein, 35% carbohydrate, and 45% fat) for 16 wk (n ϭ 10/group). Mice were housed at 22°C under a 12:12-h light-dark cycle with food and water provided ad libitum. Food intake and body weight were monitored weekly.
Body composition, thermographic imaging, and core temperature measurement. Body composition was determined using nuclear magnetic resonance (NMR, Echo Medical Systems), as previously described (54) . Thermal images were captured using a SC620 infrared camera (FLIR Systems) and quantified with the ExaminIR software (ThermoVision). Core body temperature was measured using a rectal probe (Harvard Apparatus).
Quantitative PCR and Western blot analysis. RNA extraction was performed with TRIzol Reagent (Life Technologies) and was followed by cDNA synthesis with SuperScript III reverse transcriptase (Life Technologies). SYBR Green qPCR was run using an Applied Biosystems 7300 real-time PCR System. Relative gene expression was calculated using DataAssist v3.01 software (Applied Biosystems), using Rplp0 as housekeeping. The primers used were Rplp0 forward 5=-GGGCATCACCACGAAAATCTC-3=, reverse 5=-CT-GCCGTTGTCAAACACCT-3=; Fabp3 forward 5=-ACCTGGA-AGCTAGTGGACAG-3=, reverse 5=-TGATGGTAGTAGGCTTG-GTCAT-3=; InsR, forward 5=-CCTGGTTATCTTCGAGATGGTCC-3=, reverse 5=-CCCCACATTCCTCGTTGTCA-3=; and Glut4, forward 5=-GTGACTGGAACACTGGTCCTA-3=, reverse 5=-CCAGC-CACGTTGCATTGTAG-3=.
For Western blot analysis, muscle tissue was homogenized in a buffer containing 50 mM Tris, pH 7.5, 150 mM NaCl, 10 mM MgCl 2, 0.5 mM DTT, 1 mM EDTA, 10% glycerol, 2% SDS, 1% Triton X-100, protease, and phosphatase inhibitors (Roche). After protein quantification with BCA, the samples were run on Bis-Tris or Trisacetate NuPage precast gels and blotted onto PVDF membranes. Antibodies against hormone-sensitive lipase (HSL), phosphorylated-HSL (P-HSL) S563 , and P-HSL S565 ; AMPK and P-AMPK T172 ; acetylCoA carboxylase (ACC) and P-ACC S79 ; and AKT, P-AKT S473 , and P-AKT T308 were purchased from Cell Signaling Technologies. Tubulin antibody was purchased from Sigma-Aldrich.
Twenty-four hour energy expenditure monitoring. Energy expenditure was assessed using indirect calorimetry (Oxymax/Comprehensive Laboratory Animal Monitoring System -CLAMS; Columbus Instruments). Mice were single caged with water and food ad libitum. After allowing them to acclimate for 3 days, oxygen consumption and carbon dioxide production were measured for 24 h using an air flow of 600 ml/min and an ambient temperature of 22°C. The respiratory exchange ratio (RER) was calculated as the ratio between carbon dioxide production and oxygen consumption (RER ϭ V CO2/V O2).
Single traces were analyzed with GraphPad Prism 4 generating an average fit spline function for each experimental group.
Serum chemistries. IL-15 serum levels were quantified with a Bio-Plex Pro mouse IL-15 set using a BioPlex protein array instru- Values are expressed as means Ϯ SE. NEFA, nonesterified fatty acid. NC and HFD, n ϭ 10. ****P Ͻ 0.0001, ***P Ͻ 0.001, **P Ͻ 0.01, *P Ͻ 0.05. ELISA kits were used to quantify serum levels of insulin (Crystal Chem), leptin (Millipore), and adiponectin (Millipore). Serum lipids were measured using colorimetric enzymatic assays (StanBio; Zenbio for NEFA).
Tissue composition analysis. Liver and tibialis anterior muscle (TA) frozen sections (12-m thickness) were cut and stained with Oil Red O (ORO), as previously described (23) . Liver ORO staining was quantified with CellProfiler 2.1.1 using a custom-made pipeline (18) . Muscle acylglycerols were quantified with an enzymatic colorimetric assay (StanBio). Muscle glycogen content was measured, as previously described (51) . For thin-layer chromatography (TLC), total lipids were extracted from quadriceps muscles using a modified method of Bligh and Dyer in chloroform/methanol (2:1) (13). The organic phase was obtained by centrifugation at 200 g. Lipids were dried under a gentle stream of nitrogen gas. The lipid extracts were dissolved in chloroform (200 l) and aliquots, together with standards, were separated by TLC on silica gel G-60 plates (SigmaAldrich), as previously described (22) . The neutral lipid components were separated using a mixture of n-hexane: diethyl ether:acetic acid (70:30:1), and polar lipid components were separated using a mixture of chloroform:methanol:acetic acid:water (85:15:10:3.5). After each TLC run, plates were removed, air-dried, sprayed with primuline (Sigma-Aldrich) to label lipid spots, and viewed under UV light. Spots were identified by comparison with lipid standards.
Ex vivo muscle physiology. Muscle physiological analysis was performed on isolated extensor digitorum longus (EDL) muscles using an Aurora Mouse 1200A System equipped with Dynamic Muscle Control v.5.3 software. EDL muscles were dissected and analyzed in constantly oxygenated Ringer solution (100 mM NaCl, 4.7 mM KCl, 3.4 mM CaCl 2, 1.2 mM KH2PO4, 1.2 mM MgSO4, 25 mM HEPES, 5.5 mM D-glucose, and 2% BSA) at 24°C.
For induction of fatigue, muscles were stimulated every second for 8 min using 100-Hz tetanic stimulations each lasting 330 ms. This contraction-to-exhaustion protocol allowed to reduce the force to less than 5% compared with the initial contraction, ensuring comparable values for the first steps of the recovery protocol. The recovery protocol started 1 s after the last fatigue contraction. The same stimulation (100 Hz for 330 ms) was given every 5 min for 30 min.
Muscle mitochondria preparation and 14 C-palmitate oxidation. Skeletal muscle mitochondria were isolated from limb and pectoral muscles, by differential centrifugation, as previously described (48) . The final 9,000-g pellet was resuspended in a minimal volume, such that protein concentration was ϳ25 mg/ml. Protein concentration was measured using BCA protein assay (Pierce). Fatty acid oxidation was measured in 0.5 mg/ml of skeletal muscle mitochondria using [1- 14 C]-palmitate, as previously described (48), with the exception that mitochondria isolation medium (70 mM sucrose, 22 mM mannitol, 10 mM KH 2PO4, 5 mM MgCl2, 2 mM HEPES, 1 mM EGTA, 0.2% defatted BSA, pH 7.4 at 37°C) was used as the buffer.
Glucose and insulin tolerance tests and ex vivo insulin stimulation. For glucose tolerance test (GTT), mice were fasted overnight, tail blood glucose was measured with a glucometer, glucose solution (2 g/kg) was injected intraperitoneally, and tail blood glucose was measured at 15, 30, 60, and 120 min. For insulin tolerance test (ITT), mice were fasted for 5 h in the morning, tail blood glucose was measured, human regular insulin (Humulin R) 0.75 U/kg was injected intraperitoneally, and tail blood glucose was measured at 15, 30, 60, 90, and 120 min.
For ex vivo insulin stimulation, EDL muscles were dissected from 4-h fasted mice, pinned at resting length and incubated at 37°C in oxygenated Ringer solution for 45 min to remove endogenous hormones. The muscles were then incubated for 30 min at 37°C without or with 40 U/ml insulin in the same buffer. After the incubation, tendons were removed, and muscles were frozen for Western blot and immunofluorescence analyses. For GLUT4 translocation analysis, 10-m frozen sections of EDL muscles were probed with a 1:100 dilution of GLUT4 antibody (AbCam) and counterstained with wheat germ agglutinin (Life Technologies). Six-micrometer Z-stacks were collected using a Nikon Eclypse confocal microscope at 63ϫ magnification with an additional 1.38ϫ digital zoom. Max projections were then analyzed using a bespoke CellProfiler pipeline that quantifies the amount of GLUT4 localizing on the fiber membrane.
Statistical analysis. Data are presented as means Ϯ SE and were analyzed using GraphPad Prism 4 or R (52). Unless specified differently, two-way ANOVA with Tukey's post hoc test was used for statistical analysis, testing the effect of genotype and diet. For experiments comparing the effect of genotype and diet on repeated measures, a generalized linear model was applied. When testing the effect of genotype only, one tailed t-test was used. P Ͻ 0.05 was considered statistically significant.
RESULTS

IL-15R␣
Ϫ/Ϫ mice are resistant to diet-induced obesity.
Control and IL-15R␣
Ϫ/Ϫ mice were fed a high-fat diet (HFD) or normal chow (NC), and body weights were monitored for 16 wk (Table 1) . Control mice became significantly heavier on the HFD compared with NC (47.3 Ϯ 7.5 g vs. 34.3 Ϯ 2.96 g) starting from the 6th wk of the HFD. IL-15R␣ Ϫ/Ϫ mice were resistant to DIO (39.7 Ϯ 5.25 g vs. 33.7 Ϯ 2.1 g) (Fig. 1A) . The resistance to DIO was not due to differences in daily energy intake (Fig. 1B) . Body composition analysis with NMR (Fig.  1C ) and the weights of major adipose tissue depots [subcutaneous inguinal white adipose tissue (iWAT), epididimal gonadal white adipose tissue (gWAT), and brown adipose tissue (BAT)] at 16 wk of NC or HFD (Fig. 1D) , confirmed that HFD-fed IL-15R␣ Ϫ/Ϫ mice were leaner than HFD controls. ORO staining showed decreased hepatic fat in IL-15R␣ Ϫ/Ϫ mice on HFD (Fig. 1, E and F) . Serum cholesterol levels were elevated in both genotypes on a HFD (Table 2) . Serum ketone levels were reduced on HFD in both genotypes and were 50% lower in IL-15R␣ Ϫ/Ϫ NC compared with controls on the same diet ( Table 2) . Triglycerides (TG) and nonesterified fatty acids (NEFA) were not significantly affected by HFD or genotype.
IL-15R␣
Ϫ/Ϫ mice have decreased RER. Oxygen consumption rates over 24 h were similar between genotypes and increased on a HFD. In IL-15R␣ Ϫ/Ϫ mice, however, the induction was 20% higher than in controls ( Fig. 2A) . Administration of HFD and the consequent development of obesity are associated with a decrease in RER due to fatty acid oxidation (20) . This change was evident when control mice received HFD. In IL-15R␣ Ϫ/Ϫ mice, low RER values consistent with higher fatty acid oxidation were also observed when mice were fed the NC diet (Fig. 2B) . Core temperature was decreased by HFD in control mice but increased by ϳ1°C in IL-15R␣ Ϫ/Ϫ (Fig. 2C ).
Ϫ/Ϫ muscles efficiently store and utilize fatty acids. We asked whether differences in muscle metabolism could account for the increased energy expenditure and low RER. We looked at two primary forms of energy storage used by muscle: glycogen and acylglycerols. Glycogen content was increased by HFD with no differences between genotypes (Fig.  3A) . Quantification of intramyofibrillar acylglycerols (Fig. 3B) , as well as ORO staining of neutral lipids (Fig. 3C) (Ra Ϫ/Ϫ ) EDL muscles after the ex vivo recovery protocol (n ϭ 5). C: mRNA analysis of Fabp3 in EDL muscles after the ex vivo recovery protocol (n ϭ 3). D: representative Western blot analysis and densitometries of AMPK and ACC in EDL muscles after the ex vivo recovery protocol (n ϭ 4). E:
14 C-palmitate uptake and oxidation by skeletal muscle isolated mitochondria (n ϭ 6). ASP, acid soluble product. 14 C-palmitate uptake and oxidation results were analyzed using Wilcoxon matched-pairs signed rank test. G: significant effect of genotype; D: significant effect of diet; I: significant interaction between genotype and diet. ****P Ͻ 0.0001, ***P Ͻ 0.001, **P Ͻ 0.01, *P Ͻ 0.05.
HFD caused lipid accumulation in skeletal muscles of both genotypes. On NC, IL-15R␣
Ϫ/Ϫ muscles accumulated significantly more lipids than controls (20% more by biochemical quantification and 15% by ORO compared with controls on NC). TLC-based analysis of the lipid content showed that controls on the HFD had a significant increase in TG. On the other hand, IL-15R␣ Ϫ/Ϫ muscles accumulated diacylglycerols and monoacylglycerols (DAG and MAG, respectively) and free fatty acids (FFA) rather than TG (Fig. 3D, quantified in  Fig. 3E ). Phosphatidylserine (PS) and phosphatidylcholine (PC) also tended to increase in IL-15R␣ Ϫ/Ϫ samples. DAG and MAG deposition in muscle is not uncommon in subjects exposed to a HFD (57), or with insulin resistance (3). Elevated DAG levels have been also noted in muscles of endurancetrained subjects (1) . Given the endurance phenotype of IL-15R␣ Ϫ/Ϫ mice (34), we asked whether the presence of these intermediate lipid species could confer a metabolic advantage for recovery from muscle fatigue.
IL-15R␣
Ϫ/Ϫ muscle utilizes fatty acids to recover more efficiently from fatigue. Fatty acid oxidation plays an important role during prolonged exercise (45) , marathon running or other endurance sports (5), and during postexercise recovery (16) . In particular, after fatiguing conditions, triacylglycerol utilization increases to provide energy and to replenish the glycogen stores depleted during exercise (15, 27) . We designed an experimental protocol reproducing in vivo exercise-to-exhaustion in ex vivo EDL muscles, to promote FFA oxidation during the recovery phase. A fatigue stimulation protocol consisting of a series of tetanic contractions repeating every second for 8 min was applied to fatigue muscles to a comparable level (less than 5% of the initial force). After the last fatiguing contraction, one tetanic stimulation every 5 min was used to monitor the force recovery over a period of 30 min (Fig. 4A) . IL-15R␣ Ϫ/Ϫ EDLs recovered from fatigue better than controls (back to 43.3% of the prefatigue force for IL-15R␣ Ϫ/Ϫ NC against 35.7% for controls NC). HFD significantly improved recovery in both genotypes, with IL-15R␣ Ϫ/Ϫ HFD muscles regaining ϳ57% of the original force against 53% for controls HFD (Fig. 4A) . We then used the exercised muscles to analyze the levels of HSL since it plays an important role in controlling triglycerides and cholesterol levels and, in turn, lipid utilization. Phosphorylation of residues Ser-563 and Ser-565 were higher in IL-15R␣ Ϫ/Ϫ muscles especially on a HFD (Fig. 4B) . mRNA of Fabp3 was also significantly induced by HFD in IL-15R␣ Ϫ/Ϫ vs. control muscles (proportionally to the availability of lipids in muscle and to the final force recovery from fatigue) (Fig. 4C) . FABP3 is important for binding and solubilizing fatty acids in the cytosol, facilitating their oxidation (14) . It also interacts with HSL to promote its translocation to the surface of lipid particles to hydrolyze cholesterol esters or triglycerides to free fatty acids (17) .
Utilization of fatty acids requires their conversion to acylcarnitines, mainly operated by carnitine palmitoyl-transferse 1B (CPT1B). The main regulatory mechanism for CPT1B activity is repression by malonyl-CoA generated by acetylCoA carboxylase (ACC). Muscle contraction induces AMPK activation, which results in an inhibitory phosphorylation of ACC and removal of CPT1B inhibition (7) . After the application of our contraction protocol, while Cpt1b mRNA levels were unaltered (data not shown), AMPK and ACC phosphorylation were significantly higher in IL-15R␣ Ϫ/Ϫ muscles (Fig.   4D ), suggesting that enhanced CPT1B activity could promote FFA flux into mitochondria in the muscle of IL-15R␣ Ϫ/Ϫ mice. Indeed, both uptake and oxidation of C 14 -labeled palmitate were more efficient in isolated mitochondria from 11-wk-old IL-15R␣ Ϫ/Ϫ mice vs. control mice (both fed a normal diet) (Fig. 4E) .
Altered glucose homeostasis in IL-15R␣ Ϫ/Ϫ mice. After 16 wk, blood glucose levels in IL-15R␣ Ϫ/Ϫ mice were significantly higher than in controls on either HFD or NC diets (Fig.  5A and Table 2 ). Insulin levels tended to be higher in IL-15R␣ Ϫ/Ϫ compared with controls on NC diet (Fig. 5B and Table 2 ).
Glucose tolerance was decreased in response to HFD, and worse in IL-15R␣ Ϫ/Ϫ than in control mice (Fig. 5C ). Gene expression analysis in gastrocnemius muscle showed that insulin receptor (InsR) mRNA in IL-15R␣ Ϫ/Ϫ samples both on NC and HFD was significantly decreased to the level found in controls under HFD (Fig. 5D ). Glut4 expression was not different between the two genotypes.
Interestingly, the same glycemic values were found in 8-and 14-wk-old IL-15R␣ Ϫ/Ϫ mice on normal chow (Fig. 6A) , with higher GTT (Fig. 6, B and D) , a tendency to perform worse in ITT (Fig. 6C) , and higher insulin secretion during GTT (Fig.  6E) . To test the sensitivity to insulin, we used ex vivo stimulation of EDL muscles with 40 U/ml insulin. Insulin-induced Akt phosphorylation was similar between controls and IL-15R␣ Ϫ/Ϫ (Fig. 6F) . On the same muscles, confocal analysis of GLUT4 translocation showed a 2.3-fold insulin-stimulated increase in membrane-localized GLUT4 in control 
muscles while the IL-15R␣
Ϫ/Ϫ muscles did not respond (Fig. 6, G and H) .
These data suggest that lack of IL-15R␣ Ϫ/Ϫ was associated with an age-and diet-independent glucose-intolerant, insulinresistant phenotype.
DISCUSSION
In this study, we show that lack of IL-15R␣ has important effects on energy metabolism, reflected by resistance to DIO (Fig. 1) and improved muscle recovery after fatigue (Fig. 4) . We have identified the preference for fatty acids utilization (Fig. 2) , as the primary mechanism underlying the profound effects that loss of IL-15R␣ has on metabolism. These findings are consistent with predictions based on previous studies where loss of IL-15R␣ was shown to cause significant changes in muscle physiology by promoting an oxidative switch and mitochondrial biogenesis in fast muscles (34) .
The protection from diet-induced weight gain was accompanied by a reduction in adiposity and liver triglyceride accumulation compared with controls ( Fig. 1) .
CLAMS analysis showed a constant preference for fatty acid utilization in IL-15R␣ Ϫ/Ϫ mice on both diets (Fig. 2B ). The core temperature was higher in IL-15R␣ Ϫ/Ϫ mice on HFD, consistent with increased energy expenditure (Fig.  2C) . Given the already documented spontaneous activity and endurance (34) and considering the higher availability of acylglycerols in IL-15R␣ Ϫ/Ϫ muscles (Fig. 3) , we hypothesized that muscle could be a primary site for their utilization.
We applied an ex vivo physiology protocol composed of an initial exercise-to-exhaustion phase followed by a recovery phase. The goal of this strategy was to bring the muscle to a metabolic state in which carbohydrate oxidation is discouraged in favor of the utilization of triglyceride-derived intramuscular Ϫ/Ϫ (Ra Ϫ/Ϫ ) EDL after ex vivo stimulation with 40 U/ml insulin (n ϭ 4). G: representative confocal images of GLUT4 (green) translocation to the muscle plasma membrane (PM; red) after ex vivo stimulation with 40 U/ml insulin (n ϭ 4). H: quantification of changes in GLUT4 localization at the PM. Each point represents the ratio between stimulated and unstimulated GLUT4 membrane signal. Scale bar: 30 m. ****P Ͻ 0.0001, **P Ͻ 0.01, *P Ͻ 0.05. fatty acids. The application of an exercise-to-exhaustion protocol drastically reduces the intramuscular glycogen pools, leading to decreased glycolytic flux and low ATP synthesis (4, 27) . In this context, fatty acid oxidation is predominant (5, 15, 45) and becomes an essential fuel source for aerobic energy during the recovery phase (16) . We propose that increased acylglycerol availability in IL-15R␣ Ϫ/Ϫ muscles (Fig. 3) , together with more efficient mitochondrial ␤-oxidation (Fig. 4) , conferred a significant metabolic advantage under recovery conditions. Consistently, after repetitive muscle contractions, IL-15R␣ Ϫ/Ϫ muscles showed higher levels of Fabp3 mRNA, and a stronger activation of HSL and AMPK/ACC/CPT1B pathway to promote FFA oxidation.
Consistently with the increased DAG levels in muscle and despite the active phenotype, IL15Ra
Ϫ/Ϫ mice were glucoseintolerant and insulin-resistant, even on NC (Figs. 5 and 6 ). These findings are interesting since in numerous mouse models (6, 41, 58, 60) , DIO resistance is accompanied by improved glucose homeostasis. Compared with controls, IL-15R␣ Ϫ/Ϫ mice had hyperglycemia, hyperinsulinemia, and higher insulin secretion during GTT, independently of age (Figs. 5 and 6). Ex vivo stimulation of EDL muscles with 40 U/ml insulin caused a 2.3-fold increase in GLUT4 localization at the plasma membrane in control muscles, but was ineffective in IL-15R␣ Ϫ/Ϫ , indicating that these muscles are insulin-resistant (Fig. 6) . Despite the clear glucose intolerance, normal insulin-stimulated Akt phosphorylation suggested that the site of dysregulation may be downstream of Akt.
The dichotomy of resistance to DIO and altered glucose homeostasis that we noted is not unprecedented (9, 50) and would suggest that in IL-15R␣ Ϫ/Ϫ mice, the increased utilization of fatty acids competes with utilization of glucose as a substrate (12, 26, 42) . Similarly, muscle-specific PGC-1␣ overexpression also induces a muscle oxidative phenotype with constitutively higher fat oxidation at the expense of glucose tolerance (9) .
Interestingly, the decreased adiposity in IL15Ra Ϫ/Ϫ mice is similar to what is reported when IL-15 is oversecreted from muscle (39) . The connection between the two models may reside in the increased availability of free circulating IL-15.
On the other hand, the glucose phenotype seen in our study is opposite of that reported for IL-15 overexpression (2, 38). The effect on glucose homeostasis may, therefore, require the interaction between IL-15 and IL-15R␣.
Glucose metabolism and insulin sensitivity are also important for coordinating the immune response. A shift toward increased glucose uptake is a general feature of activated immune proinflammatory cells (30) . Impaired glucose homeostasis markedly affects lymphocyte proliferation and homing (31) . Consistently with these data, IL-15R␣ Ϫ/Ϫ , mice have significantly decreased proliferation and homing of lymphocytes to peripheral lymph nodes (19) . IL-15R␣ appears to be directly involved in the control of insulin sensitivity and glucose homeostasis. From an evolutionary perspective, IL-15R␣ may have been relevant for maintaining body mass when food became limiting (i.e., famine), while in a calorie-rich environment, its loss could effectively limit fat overaccumulation.
Perspectives and Significance
The present study highlights the effects that inhibition of the IL-15/IL-15R␣ proinflammatory signaling has on whole body metabolism and recovery from fatigue. Inflammation increases the risk of developing obesity and other noncommunicable diseases. Lifestyle (i.e., stress, alteration of circadian rhythms) and environmental factors (i.e., air pollution) are just some of the factors contributing to the instauration of chronic inflammatory states in subjects of all ages.
Our findings suggest an important role for IL-15R␣ in connecting inflammation with energy balance in the whole body and particularly in muscle. The effects on other metabolic tissues (i.e., liver and adipose tissue), and the possibility to design specific modulatory strategies for protecting from DIO possibly without altering glucose homeostasis, remain to be investigated.
